Previous Close | 3.88 |
1-Year Change | 88.35% |
6-Months Change | 7.48% |
3-Months Change | 28.9% |
Moving Avg (50d) | 3.258 |
Moving Avg (200d) | 3.2326 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 270.9M |
Beta (3-Years) | 2.04 |
Revenue Growth (ttm) | -44.27% |
Net Profit Margin (ttm) | -110.4% |
Return On Assets (ttm) | -52.86% |
EPS (ttm) | -1.2 |
PE Ratio (ttm) | -3.23 |
Dividend Yield | % |
Asset Description: | Codexis, Inc. |
Predicted Direction: | Buy |
Signal Strength: | Buy |
Forecast Date: | 2024-11-19 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
4.243 | 4.113 | 4.027 | 3.897 | 3.68 | 3.464 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Biotechnology |
Country: | United States |